HC Wainwright & Co. Reiterates Buy on Greenwich LifeSciences, Maintains $36 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Yi Chen has reiterated a Buy rating on Greenwich LifeSciences (NASDAQ:GLSI) and maintained a $36 price target on the stock.

February 28, 2024 | 6:23 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
HC Wainwright & Co. analyst Yi Chen reaffirmed a Buy rating on Greenwich LifeSciences with a $36 price target.
The reiteration of a Buy rating and the maintenance of a $36 price target by a reputable analyst could instill confidence among investors and potentially lead to a positive short-term impact on GLSI's stock price. Analyst ratings, especially those that are positive, can influence market perception and investor sentiment.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100